131 related articles for article (PubMed ID: 14618327)
21. Occupational radiation exposure and thyroid cancer incidence in a cohort of U.S. radiologic technologists, 1983-2013.
Kitahara CM; Preston DL; Neta G; Little MP; Doody MM; Simon SL; Sigurdson AJ; Alexander BH; Linet MS
Int J Cancer; 2018 Nov; 143(9):2145-2149. PubMed ID: 29355960
[TBL] [Abstract][Full Text] [Related]
22. Lymph nodes metastases in differentiated thyroid cancer--prognostic value and surgical results with 430 patients for 30 years period (1980-2010).
Petkov R; Katev N; Todorov G; Mladenovski V; Yaramov N; Sokolov M
Khirurgiia (Sofiia); 2011; (1):5-11. PubMed ID: 23847796
[TBL] [Abstract][Full Text] [Related]
23. Thyroid nodularity and cancer among Chernobyl cleanup workers from Estonia.
Inskip PD; Hartshorne MF; Tekkel M; Rahu M; Veidebaum T; Auvinen A; Crooks LA; Littlefield LG; McFee AF; Salomaa S; Makinen S; Tucker JD; Sorensen KJ; Bigbee WL; Boice JD
Radiat Res; 1997 Feb; 147(2):225-35. PubMed ID: 9008215
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
25. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
26. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
27. Importance of lymph node metastases in follicular thyroid cancer.
Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
Włoch J; Czarniecka A; Turska M; Wilgus J
Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
[TBL] [Abstract][Full Text] [Related]
29. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
30. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
31. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
32. Papillary thyroid cancer: controversies in the management of neck metastasis.
Davidson HC; Park BJ; Johnson JT
Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855
[TBL] [Abstract][Full Text] [Related]
33. Radiation-Induced Thyroid Cancer: Gender-Related Disease Characteristics and Survival.
Nachalon Y; Katz O; Alkan U; Shvero J; Popovtzer A
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):242-6. PubMed ID: 26443720
[TBL] [Abstract][Full Text] [Related]
34. [Small thyroid carcinomas: biological characteristics, diagnosis and therapy].
Gemsenjäger E; Schweizer I
Schweiz Med Wochenschr; 1999 May; 129(18):681-90. PubMed ID: 10407941
[TBL] [Abstract][Full Text] [Related]
35. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
36. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
37. Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure.
Ho WL; Zacharin MR
Eur J Pediatr; 2016 May; 175(5):677-83. PubMed ID: 26805408
[TBL] [Abstract][Full Text] [Related]
38. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
Liu WS; Qi YF; Tang PZ
Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
[TBL] [Abstract][Full Text] [Related]
39. [Differentiated thyroid carcinoma: prognostic factors].
Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
[TBL] [Abstract][Full Text] [Related]
40. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.
Taylor AJ; Croft AP; Palace AM; Winter DL; Reulen RC; Stiller CA; Stevens MC; Hawkins MM
Int J Cancer; 2009 Nov; 125(10):2400-5. PubMed ID: 19610069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]